Barinthus Biotherapeutics plc. has 2 Schedule 13D or 13G filings on record since 2026-04-13. 1 holder's latest filing reports 5% or more of american depositary shares, each representing one ordinary share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| International Generosity Foundation Trust | 6.7% | 2,734,189 | SCHEDULE 13D, 2026-04-13 | 2026-02-03 |
| Oxford Science Enterprises plc | 0% | 0 | SCHEDULE 13G/A, 2026-09-11 | 2026-09-09 |
Purpose of Transaction (Item 4)
International Generosity Foundation Trust
The Reporting Person acquired the securities for investment purposes and in connection with its charitable activities. The Reporting Person may, from time to time, sell or otherwise dispose of some or all of the securities, including to support its charitable purposes, or acquire additional securities, depending on market conditions and other factors. Except as set forth above, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions described in Items 4(a) through (j) of Schedule 13D.Item 4 of the SCHEDULE 13D filed 2026-04-13
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-04-13 | International Generosity Foundation Trust | 6.7% | SCHEDULE 13D |
| 2026-09-11 | Oxford Science Enterprises plc | 0% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Barinthus Biotherapeutics plc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.